Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125474031 | 12547403 | 1 | I | 20160704 | 20160711 | 20160711 | EXP | GB-ASTRAZENECA-2016SE72843 | ASTRAZENECA | 70.00 | YR | F | Y | 65.00000 | KG | 20160712 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125474031 | 12547403 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 10.0MG UNKNOWN | Y | U | 19810 | 10 | MG | ||||||
| 125474031 | 12547403 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125474031 | 12547403 | 1 | Hiatus hernia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125474031 | 12547403 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125474031 | 12547403 | Arthralgia | |
| 125474031 | 12547403 | Asthenia | |
| 125474031 | 12547403 | Musculoskeletal pain | |
| 125474031 | 12547403 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125474031 | 12547403 | 1 | 201601 | 20160604 | 0 | |
| 125474031 | 12547403 | 2 | 201604 | 0 |